HALEON PLC (H6D0.DE) Stock Fundamental Analysis

FRA:H6D0 • GB00BMX86B70

4.665 EUR
+0.1 (+2.15%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall H6D0 gets a fundamental rating of 3 out of 10. We evaluated H6D0 against 52 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of H6D0 while its profitability can be described as average. H6D0 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year H6D0 was profitable.
  • H6D0 had a positive operating cash flow in the past year.
  • In the past 5 years H6D0 has always been profitable.
  • In the past 5 years H6D0 always reported a positive cash flow from operatings.
H6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFH6D0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • The Return On Assets of H6D0 (4.20%) is comparable to the rest of the industry.
  • With a Return On Equity value of 8.92%, H6D0 perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
  • H6D0 has a Return On Invested Capital (6.11%) which is in line with its industry peers.
  • H6D0 had an Average Return On Invested Capital over the past 3 years of 6.15%. This is significantly below the industry average of 14.12%.
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROIC 6.11%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
H6D0.DE Yearly ROA, ROE, ROICH6D0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

  • Looking at the Profit Margin, with a value of 12.84%, H6D0 is in line with its industry, outperforming 48.08% of the companies in the same industry.
  • In the last couple of years the Profit Margin of H6D0 has grown nicely.
  • The Operating Margin of H6D0 (21.31%) is comparable to the rest of the industry.
  • H6D0's Operating Margin has improved in the last couple of years.
  • H6D0's Gross Margin of 60.75% is on the low side compared to the rest of the industry. H6D0 is outperformed by 63.46% of its industry peers.
  • In the last couple of years the Gross Margin of H6D0 has remained more or less at the same level.
Industry RankSector Rank
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
H6D0.DE Yearly Profit, Operating, Gross MarginsH6D0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), H6D0 is destroying value.
  • H6D0 has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for H6D0 has been reduced compared to 5 years ago.
  • H6D0 has a worse debt/assets ratio than last year.
H6D0.DE Yearly Shares OutstandingH6D0.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
H6D0.DE Yearly Total Debt VS Total AssetsH6D0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • Based on the Altman-Z score of 1.80, we must say that H6D0 is in the distress zone and has some risk of bankruptcy.
  • H6D0's Altman-Z score of 1.80 is on the low side compared to the rest of the industry. H6D0 is outperformed by 63.46% of its industry peers.
  • The Debt to FCF ratio of H6D0 is 5.11, which is a neutral value as it means it would take H6D0, 5.11 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.11, H6D0 is in line with its industry, outperforming 59.62% of the companies in the same industry.
  • A Debt/Equity ratio of 0.53 indicates that H6D0 is somewhat dependend on debt financing.
  • H6D0's Debt to Equity ratio of 0.53 is fine compared to the rest of the industry. H6D0 outperforms 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Altman-Z 1.8
ROIC/WACC0.74
WACC8.22%
H6D0.DE Yearly LT Debt VS Equity VS FCFH6D0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

  • H6D0 has a Current Ratio of 0.98. This is a bad value and indicates that H6D0 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • H6D0's Current ratio of 0.98 is on the low side compared to the rest of the industry. H6D0 is outperformed by 80.77% of its industry peers.
  • A Quick Ratio of 0.78 indicates that H6D0 may have some problems paying its short term obligations.
  • H6D0's Quick ratio of 0.78 is on the low side compared to the rest of the industry. H6D0 is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.78
H6D0.DE Yearly Current Assets VS Current LiabilitesH6D0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.59% over the past year.
  • The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
  • The Revenue has decreased by -0.61% in the past year.
  • H6D0 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.78% yearly.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%0.68%

3.2 Future

  • H6D0 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.15% yearly.
  • The Revenue is expected to grow by 3.27% on average over the next years.
EPS Next Y5.72%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
EPS Next 5Y7.15%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
H6D0.DE Yearly Revenue VS EstimatesH6D0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
H6D0.DE Yearly EPS VS EstimatesH6D0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 22.21, the valuation of H6D0 can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as H6D0.
  • H6D0's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.10.
  • H6D0 is valuated rather expensively with a Price/Forward Earnings ratio of 19.57.
  • H6D0's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. H6D0 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.21
Fwd PE 19.57
H6D0.DE Price Earnings VS Forward Price EarningsH6D0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • H6D0's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. H6D0 is cheaper than 76.92% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of H6D0 indicates a rather cheap valuation: H6D0 is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.13
EV/EBITDA 9.42
H6D0.DE Per share dataH6D0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.89
PEG (5Y)1.26
EPS Next 2Y7.77%
EPS Next 3Y8.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.67%, H6D0 has a reasonable but not impressive dividend return.
  • H6D0's Dividend Yield is comparable with the industry average which is at 1.89.
  • H6D0's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
H6D0.DE Yearly Dividends per shareH6D0.DE Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.02 0.04 0.06

5.3 Sustainability

  • H6D0 pays out 39.53% of its income as dividend. This is a sustainable payout ratio.
DP39.53%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
H6D0.DE Yearly Income VS Free CF VS DividendH6D0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
H6D0.DE Dividend Payout.H6D0.DE Dividend Payout, showing the Payout Ratio.H6D0.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HALEON PLC

FRA:H6D0 (2/27/2026, 7:00:00 PM)

4.665

+0.1 (+2.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-25
Inst Owners58.32%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap20.77B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts80
Price Target5.12 (9.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.28%
PT rev (3m)4.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 22.21
Fwd PE 19.57
P/S 1.61
P/FCF 9.13
P/OCF 7.87
P/B 1.12
P/tB N/A
EV/EBITDA 9.42
EPS(TTM)0.21
EY4.5%
EPS(NY)0.24
Fwd EY5.11%
FCF(TTM)0.51
FCFY10.95%
OCF(TTM)0.59
OCFY12.7%
SpS2.89
BVpS4.16
TBVpS-2.59
PEG (NY)3.89
PEG (5Y)1.26
Graham Number4.44
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 8.92%
ROCE 8.4%
ROIC 6.11%
ROICexc 6.63%
ROICexgc 4145.85%
OM 21.31%
PM (TTM) 12.84%
GM 60.75%
FCFM 17.65%
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.11
Debt/EBITDA 3.18
Cap/Depr 98.15%
Cap/Sales 2.83%
Interest Coverage 6.65
Cash Conversion 84.66%
Profit Quality 137.52%
Current Ratio 0.98
Quick Ratio 0.78
Altman-Z 1.8
F-Score6
WACC8.22%
ROIC/WACC0.74
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.72%
EPS Next 2Y7.77%
EPS Next 3Y8.45%
EPS Next 5Y7.15%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%0.68%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.27%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.42%
EBIT Next 5Y7.75%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%

HALEON PLC / H6D0.DE FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC?

ChartMill assigns a fundamental rating of 3 / 10 to H6D0.DE.


Can you provide the valuation status for HALEON PLC?

ChartMill assigns a valuation rating of 4 / 10 to HALEON PLC (H6D0.DE). This can be considered as Fairly Valued.


How profitable is HALEON PLC (H6D0.DE) stock?

HALEON PLC (H6D0.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for H6D0 stock?

The financial health rating of HALEON PLC (H6D0.DE) is 2 / 10.


How sustainable is the dividend of HALEON PLC (H6D0.DE) stock?

The dividend rating of HALEON PLC (H6D0.DE) is 3 / 10 and the dividend payout ratio is 39.53%.